Biological response modifiers and differentiation inducers. Current status in cancer research.
D000276:Adjuvants, Immunologic; D001388:Aziridines / Q000494:pharmacology; D001428:Bacterial Vaccines / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects*; D003524:Cyclosporins / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D005936:Glucans / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D007930:Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D007978:Levamisole / Q000494:pharmacology; D008094:Lithium / Q000494:pharmacology; D009369:Neoplasms / Q000503:physiopathology*; D010455:Peptides / Q000494:pharmacology; D012176:Retinoids / Q000494:pharmacology; D012643:Selenium / Q000494:pharmacology
D000276:Adjuvants, Immunologic; D001388:Aziridines; D001428:Bacterial Vaccines; D003524:Cyclosporins; D005936:Glucans; D006728:Hormones; D010455:Peptides; D012176:Retinoids; D007978:Levamisole; C016866:azimexon; D008094:Lithium; D007930:Leucine; D012643:Selenium; C012211:ubenimex; D004121:Dimethyl Sulfoxide